The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock.
D000311:Adrenal Glands / Q000503:physiopathology; D002302:Cardiac Output; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000627:therapeutic use; D008833:Microcirculation; D010100:Oxygen / Q000097:blood; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011311:Pressoreceptors / Q000503:physiopathology; D012769:Shock / Q000188:drug therapy*; D012770:Shock, Cardiogenic / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy; D012774:Shock, Traumatic / Q000188:drug therapy; D014655:Vascular Resistance
D005938:Glucocorticoids; D010643:Phenoxybenzamine; D007545:Isoproterenol; D010100:Oxygen